Equity Report on ACI
ACI Limited is one of the largest business conglomerates in Bangladesh tracking a 5Y revenue CAGR of 16.3%; the company has 63.92% of free float market capitalization up to May 2024.
Tag: company analysis
Company analysis is a thorough evaluation of a company’s growth, prospects, performance, competitiveness, and risks. The internal and external stakeholders of any business conduct company analysis when necessary to take action or to make decisions and strategic plans. For finance providers and investors it’s very important to analyze any company with a view to making a prudent investment decision.
Tag: company analysis
Company analysis is a thorough evaluation of a company’s growth, prospects, performance, competitiveness, and risks. The internal and external stakeholders of any business conduct company analysis when necessary to take action or to make decisions and strategic plans. For finance providers and investors it’s very important to analyze any company with a view to making a prudent investment decision.
Equity Coverage on Marico Bangladesh Limited
Marico Bangladesh Limited is one of the leading consumer products company in Bangladesh with a CAGR of 13% in terms of revenue over the last five years. Parachute Coconut Oil is the most trustworthy brand which owns more than 80% of market share in the coconut oil category and also contribute about 63.6%(average) in revenue mix of the company.
Equity Coverage on Dhaka Bank PLC.
Dhaka Bank PLC. (DHAKABANK) is a leading private commercial bank of Bangladesh which provides wide array of financial products and services that includes all kinds of conventional and Islamic banking activities. The bank is one of the largest private sector commercial bank in Bangladesh in terms of total assets, which stood at BDT 347,693 million, as at the end of 2022 with a CAGR of 8.5% over the past five years.
Equity Coverage on ACME Laboratories Ltd.
ACMELAB was founded in 1954 as a proprietorship firm that was converted to a private limited company namely ACME Laboratories Limited (ACMELAB). Currently, ACMELAB manufactures more than 800 branded generic products covering broader therapeutic categories .
RIL Company Analysis – RENATA
The pharmaceuticals sector as a whole has great potential ahead given the country’s population of 16 crores and the high economic growth. It is expected to have an annual growth rate of more than 12% during the next few years. Bangladesh’s per capita healthcare spending is nearer the bottom of the list among the Asian…